Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPEX/4183 stock hub

TPEX/4183 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4183is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

333.2M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4183

In the news

Latest news · TPEX/4183

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-7.4

P25 -16.2P50 0.3P75 9.8

ROIC-6.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4183 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

TWD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	109
Employees Change	-7%
Employees Change Percent	-6.03
Enterprise value	TWD 374.5M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Isin	TW0004183009
Last refreshed	2026-05-10
Market cap	TWD 333.2M
Price	TWD 14
Price currency	TWD
Rev Per Employee	4,068,256.88x
Sector	Healthcare
Sic	3845
Symbol	tpex/4183
Website	https://www.epsbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.4%
EV Earnings	-17.55x
EV/FCF	-8.23x
EV/Sales	0.84x
FCF yield	-13.65%
P/B ratio	1.24x
P/S ratio	0.75x
PE Ratio10 Y	35.44x
PE Ratio5 Y	24.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.45%
EBITDA Margin	-1.73%
Gross margin	17.22%
Gross Profit	TWD 76.3M
Gross Profit Growth	-17.76%
Gross Profit Growth Q	-59.39%
Gross Profit Growth3 Y	-10.57%
Gross Profit Growth5 Y	-9.38%
Net Income	TWD -21.3M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-5.06%
Profit Margin	-4.81%
Profit Per Employee	TWD -195,743
Roa5y	1.59
ROCE	-5.41
ROE	-7.44
Roe5y	4.86
ROIC	-6.48
Roic5y	5.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.91%
Cagr1y	-24.52%
Cagr3y	-8.25%
Cagr5y	-4.67%
Div CAGR10	5.29%
Div CAGR3	-11.91%
Div CAGR5	-11%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-7.26x
Revenue Growth Q	-49.28x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	0.13x
Revenue Growth5 Y	-0.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	TWD 495.3M
Cash	TWD 95.4M
Current Assets	TWD 318.1M
Current Liabilities	TWD 130.7M
Debt	TWD 136.7M
Debt Equity	TWD 0.51
Debt FCF	TWD -3
Equity	TWD 268.8M
Interest Coverage	-9.59
Liabilities	TWD 226.5M
Long Term Assets	TWD 177.2M
Long Term Liabilities	TWD 95.8M
Net Cash	TWD -41.3M
Net Cash By Market Cap	TWD -12.4
Net Debt Equity	TWD 0.15
Tangible Book Value	TWD 265.9M
Tangible Book Value Per Share	TWD 11.17
WACC	3.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.43
Net Working Capital	TWD 135.2M
Quick ratio	1.69
Working Capital	TWD 187.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-16.25%
Dividend Growth Years	0%
Dividend per share	TWD 0.67
Dividend Years	10
Dividend Yield	4.84%
Ex Div Date	2025-08-28
Last Dividend	TWD 0.67
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	9.44%
1Y total return	-24.5%
200-day SMA	17.83
3Y total return	-22.78%
50-day SMA	15.54
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.27%
All Time High	51.57
All Time High Change	-72.85%
All Time High Date	2017-02-22
All Time Low	10.93
All Time Low Change	28.09%
All Time Low Date	2014-10-17
ATR	0.32
Beta	0.08
Beta1y	-0.01
Beta2y	0.18
Ch YTD	-15.66
High	14
High52	21.45
High52 Date	2025-06-23
High52ch	-34.73%
Low	13.55
Low52	13.45
Low52 Date	2026-05-07
Low52ch	4.09%
Ma50ch	-9.93%
Price vs 200-day SMA	-21.49%
RSI	35.14
RSI Monthly	26.9
RSI Weekly	18.53
Sharpe ratio	-1.51x
Sortino ratio	-1.79
Total Return	4.84%
Tr YTD	-15.66
Tr1m	-10.54%
Tr1w	-2.1%
Tr3m	-14.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -19.7M
Operating margin	-4.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,782,027%
Net Borrowing	33,915,000
Shares Insiders	57.04%
Shares Out	23,800,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -45.5M
Average Volume	11,368.55x
Bv Per Share	11.29
CAPEX	TWD -17.4M
Ch10y	-23.5
Ch1m	-10.54
Ch1w	-2.1
Ch1y	-27.08
Ch3m	-14.37
Ch3y	-31.03
Ch5y	-36.36
Ch6m	-21.13
Change	4.09%
Change From Open	2.94
Close	13.45
Days Gap	1.12
Depreciation Amortization	12,060,000
Dollar Volume	112,000
Earnings Date	2026-05-07
EBIT	TWD -19.7M
EBITDA	TWD -7.7M
EPS	TWD -0.9
F Score	0
FCF	TWD -45.5M
FCF EV Yield	-12.15x
FCF Per Share	TWD -1.91
Financing CF	17,969,000
Fiscal Year End	December
Founded	2,006
Income Tax	TWD -1.1M
Investing CF	-18,984,000
Is Primary Listing	1
Last Earnings Date	2025-11-05
Last Report Date	2026-03-31
Last Split Date	2014-10-08
Last Split Type	Forward
Ma150	17.08
Ma150ch	-18.04%
Ma20	14.76
Ma20ch	-5.12%
Net CF	-30,253,000
Open	13.6
Payment Date	2025-09-26
Position In Range	100
Ppne	165,887,000
Price Date	2026-05-08
Ptbv Ratio	1.25
Relative Volume	0.72x
Revenue	443,440,000x
Tax By Revenue	-0.25x
Tr6m	-21.13%
Volume	8,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4183 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.8%

$0.67 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-11.0%

0 consecutive years of growth

Total shareholder yield

+4.8%

Next ex-dividend date: 2025-08-28

Performance

TPEX/4183 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4183?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+57.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/4183 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.1

Neutral momentum band

Price vs 200-day MA

-21.5%

50/200-day relationship not available

Beta (5Y)

0.08

Less volatile than the market

Sharpe ratio

-1.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4183

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4183 stock rating?

tpex/4183 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4183 analysis?

The full report lives at /stocks/tpex/4183/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4183?

The latest report frames tpex/4183 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4183 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.